NPPA caps prices of 9 non-scheduled cancer drugs by up to 87%1 min read . Updated: 15 May 2019, 09:09 PM IST
- Trade margin of the 9 non-scheduled cancer drugs capped at 30%
- The new list of drugs is in continuation to the government’s efforts to curb profiteering on vital drugs
In continuation to its efforts to bring down drugs prices, India’s drug pricing regulator on Wednesday capped the prices of 9 non-scheduled cancer drugs by up to 87%, capping their trade margin at 30%.
Select your Category
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more